Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma

Summary. The aim of the work was to study clinical and pathological factors affecting the prognosis of the disease in patients with stage III–IVA-B oral squamous cell carcinoma (OSCC). Materials and Methods: A retrospective review of medical records of 234 patients with stage III–IVA-B OSCC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Kravets, O.V., Protsyk, V.S., Burtyn, O.V., Hlynin, O.V., Hurianov, V.H.
Format: Artikel
Sprache:English
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-243
record_format ojs
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:41:24Z
collection OJS
language English
topic clinical and pathological prognostic factors
oral squamous cell carcinoma
spellingShingle clinical and pathological prognostic factors
oral squamous cell carcinoma
Kravets, O.V.
Protsyk, V.S.
Burtyn, O.V.
Hlynin, O.V.
Hurianov, V.H.
Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
topic_facet clinical and pathological prognostic factors
oral squamous cell carcinoma
clinical and pathological prognostic factors
oral squamous cell carcinoma
format Article
author Kravets, O.V.
Protsyk, V.S.
Burtyn, O.V.
Hlynin, O.V.
Hurianov, V.H.
author_facet Kravets, O.V.
Protsyk, V.S.
Burtyn, O.V.
Hlynin, O.V.
Hurianov, V.H.
author_sort Kravets, O.V.
title Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
title_short Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
title_full Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
title_fullStr Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
title_full_unstemmed Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
title_sort clinical and pathological prognostic factors in patients with stage iii–iva-b oral squamous cell carcinoma
title_alt Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
description Summary. The aim of the work was to study clinical and pathological factors affecting the prognosis of the disease in patients with stage III–IVA-B oral squamous cell carcinoma (OSCC). Materials and Methods: A retrospective review of medical records of 234 patients with stage III–IVA-B OSCC was performed in order to study the impact of clinical and pathological factors on disease-free survival (DFS) and overall survival (OS). Results: Multivariable analysis of clinical factors revealed a statistically significant effect of stage IVA-B and the presence of surgical complications on DFS (hazard ratio (HR) = 4.9 (95% confidence interval (CI) 2.9–8.3), p < 0.001; HR = 1.6 (95% CI 1.0–2.6), p = 0.047), respectively. Stage IVA-B, the presence of surgical complications and the retromolar trigone subsite were found to have a statistically significant impact on OS (HR = 4.0 (95% CI 2.5–6.5), p < 0.001; HR = 1.8 (95% CI 1.1–2.8), p = 0.01; HR = 1.9 (95% CI 1.1–3.2), p = 0.02), respectively. Multivariable analysis of pathological factors showed a statistically significant effect of positive resection margins, the multiple lymph node involvement and high-grade tumor on DFS (HR = 3.7 (95% CI 2.0–6.6), p < 0.001; HR = 4.3 (95% CI 2.8–6.7), p < 0.001; HR = 1.6 (95% CI 1.1–2.2), p = 0.01), respectively. Besides, positive resection margins and multiple lymph node involvement were found to cause a statistically significant impact on the OS (HR = 3.6 (95% CI 2.0–6.5), p < 0.001; HR = 3.7 (95% CI 2 5–5.6), p < 0.001), respectively. A tumor grade tended to worsen OS (HR = 1.4 (95% CI 1.0–1.9), p = 0.053). Conclusion: Stage IVA, B, the presence of surgical complications, the retromolar trigone subsite, positive resection margins, multiple lymph node involvements and high-grade tumor were found to be significant clinical and pathological prognostic factors in patients with stage III–IVA-B OSCC.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-2
work_keys_str_mv AT kravetsov clinicalandpathologicalprognosticfactorsinpatientswithstageiiiivaboralsquamouscellcarcinoma
AT protsykvs clinicalandpathologicalprognosticfactorsinpatientswithstageiiiivaboralsquamouscellcarcinoma
AT burtynov clinicalandpathologicalprognosticfactorsinpatientswithstageiiiivaboralsquamouscellcarcinoma
AT hlyninov clinicalandpathologicalprognosticfactorsinpatientswithstageiiiivaboralsquamouscellcarcinoma
AT hurianovvh clinicalandpathologicalprognosticfactorsinpatientswithstageiiiivaboralsquamouscellcarcinoma
first_indexed 2025-07-17T12:16:57Z
last_indexed 2025-07-17T12:16:57Z
_version_ 1837896426149904384
spelling oai:ojs2.ex.aqua-time.com.ua:article-2432023-10-11T16:41:24Z Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma Kravets, O.V. Protsyk, V.S. Burtyn, O.V. Hlynin, O.V. Hurianov, V.H. clinical and pathological prognostic factors, oral squamous cell carcinoma clinical and pathological prognostic factors, oral squamous cell carcinoma Summary. The aim of the work was to study clinical and pathological factors affecting the prognosis of the disease in patients with stage III–IVA-B oral squamous cell carcinoma (OSCC). Materials and Methods: A retrospective review of medical records of 234 patients with stage III–IVA-B OSCC was performed in order to study the impact of clinical and pathological factors on disease-free survival (DFS) and overall survival (OS). Results: Multivariable analysis of clinical factors revealed a statistically significant effect of stage IVA-B and the presence of surgical complications on DFS (hazard ratio (HR) = 4.9 (95% confidence interval (CI) 2.9–8.3), p < 0.001; HR = 1.6 (95% CI 1.0–2.6), p = 0.047), respectively. Stage IVA-B, the presence of surgical complications and the retromolar trigone subsite were found to have a statistically significant impact on OS (HR = 4.0 (95% CI 2.5–6.5), p < 0.001; HR = 1.8 (95% CI 1.1–2.8), p = 0.01; HR = 1.9 (95% CI 1.1–3.2), p = 0.02), respectively. Multivariable analysis of pathological factors showed a statistically significant effect of positive resection margins, the multiple lymph node involvement and high-grade tumor on DFS (HR = 3.7 (95% CI 2.0–6.6), p < 0.001; HR = 4.3 (95% CI 2.8–6.7), p < 0.001; HR = 1.6 (95% CI 1.1–2.2), p = 0.01), respectively. Besides, positive resection margins and multiple lymph node involvement were found to cause a statistically significant impact on the OS (HR = 3.6 (95% CI 2.0–6.5), p < 0.001; HR = 3.7 (95% CI 2 5–5.6), p < 0.001), respectively. A tumor grade tended to worsen OS (HR = 1.4 (95% CI 1.0–1.9), p = 0.053). Conclusion: Stage IVA, B, the presence of surgical complications, the retromolar trigone subsite, positive resection margins, multiple lymph node involvements and high-grade tumor were found to be significant clinical and pathological prognostic factors in patients with stage III–IVA-B OSCC. Summary. The aim of the work was to study clinical and pathological factors affecting the prognosis of the disease in patients with stage III–IVA-B oral squamous cell carcinoma (OSCC). Materials and Methods: A retrospective review of medical records of 234 patients with stage III–IVA-B OSCC was performed in order to study the impact of clinical and pathological factors on disease-free survival (DFS) and overall survival (OS). Results: Multivariable analysis of clinical factors revealed a statistically significant effect of stage IVA-B and the presence of surgical complications on DFS (hazard ratio (HR) = 4.9 (95% confidence interval (CI) 2.9–8.3), p < 0.001; HR = 1.6 (95% CI 1.0–2.6), p = 0.047), respectively. Stage IVA-B, the presence of surgical complications and the retromolar trigone subsite were found to have a statistically significant impact on OS (HR = 4.0 (95% CI 2.5–6.5), p < 0.001; HR = 1.8 (95% CI 1.1–2.8), p = 0.01; HR = 1.9 (95% CI 1.1–3.2), p = 0.02), respectively. Multivariable analysis of pathological factors showed a statistically significant effect of positive resection margins, the multiple lymph node involvement and high-grade tumor on DFS (HR = 3.7 (95% CI 2.0–6.6), p < 0.001; HR = 4.3 (95% CI 2.8–6.7), p < 0.001; HR = 1.6 (95% CI 1.1–2.2), p = 0.01), respectively. Besides, positive resection margins and multiple lymph node involvement were found to cause a statistically significant impact on the OS (HR = 3.6 (95% CI 2.0–6.5), p < 0.001; HR = 3.7 (95% CI 2 5–5.6), p < 0.001), respectively. A tumor grade tended to worsen OS (HR = 1.4 (95% CI 1.0–1.9), p = 0.053). Conclusion: Stage IVA, B, the presence of surgical complications, the retromolar trigone subsite, positive resection margins, multiple lymph node involvements and high-grade tumor were found to be significant clinical and pathological prognostic factors in patients with stage III–IVA-B OSCC. PH Akademperiodyka 2023-06-05 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-2 10.32471/exp-oncology.2312-8852.vol-41-no-2.13081 Experimental Oncology; Vol. 41 No. 2 (2019): Experimental Oncology; 144-147 Експериментальна онкологія; Том 41 № 2 (2019): Експериментальна онкологія; 144-147 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-41-no-2 en https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-2/2019-2-2 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/